The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Stage

Acquired | Acquired

About Neotope Neuroscience

Neotope Neuroscience is a biotechnology company.On July 12th, 2021, Neotope Neuroscience was acquired by Novo Nordisk. Terms of the transaction were not disclosed.

Neotope Neuroscience Headquarter Location

77 Sir John Rogerson's Quay, Dublin Docklands

Dublin, D02 NP08,

Ireland

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Neotope Neuroscience Patents

Neotope Neuroscience has filed 1 patent.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Immune system
  • Immunology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/12/2020

3/8/2022

Monoclonal antibodies, Immunology, Immune system, Clusters of differentiation, Proteins

Grant

Application Date

2/12/2020

Grant Date

3/8/2022

Title

Related Topics

Monoclonal antibodies, Immunology, Immune system, Clusters of differentiation, Proteins

Status

Grant

  • Where is Neotope Neuroscience's headquarters?

    Neotope Neuroscience's headquarters is located at 77 Sir John Rogerson's Quay,, Dublin.

  • What is Neotope Neuroscience's latest funding round?

    Neotope Neuroscience's latest funding round is Acquired.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.